Publication:
Primaquine for Plasmodium vivax malaria treatment – Authors' reply

dc.contributor.authorRichard N. Priceen_US
dc.contributor.authorWalter R.J. Tayloren_US
dc.contributor.authorKamala Thriemeren_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.authorNicholas P. Dayen_US
dc.contributor.otherMenzies School of Health Researchen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Medicineen_US
dc.date.accessioned2020-08-25T10:35:02Z
dc.date.available2020-08-25T10:35:02Z
dc.date.issued2020-06-27en_US
dc.identifier.citationThe Lancet. Vol.395, No.10242 (2020), 1972en_US
dc.identifier.doi10.1016/S0140-6736(20)30217-8en_US
dc.identifier.issn1474547Xen_US
dc.identifier.issn01406736en_US
dc.identifier.other2-s2.0-85086872422en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/58120
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086872422&origin=inwarden_US
dc.subjectMedicineen_US
dc.titlePrimaquine for Plasmodium vivax malaria treatment – Authors' replyen_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086872422&origin=inwarden_US

Files

Collections